Literature DB >> 21623390

Activation of human ether-a-go-go related gene (hERG) potassium channels by small molecules.

Ping-zheng Zhou1, Joseph Babcock, Lian-qing Liu, Min Li, Zhao-bing Gao.   

Abstract

Human ether-a-go-go related gene (hERG) potassium (K(+)) channels play a critical role in cardiac action potential repolarization. Mutations that reduce hERG conductance or surface expression may cause congenital long QT syndrome (LQTS). However, the channels can be inhibited by structurally diverse small molecules, resulting in an acquired form of LQTS. Consequently, small molecules that increase the hERG current may be of value for treatment for LQTS. So far, nine hERG activators have been reported. The aim of this review is to discuss recent advances concerning the identification and action mechanism of hERG activators.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21623390      PMCID: PMC4085723          DOI: 10.1038/aps.2011.70

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  39 in total

1.  Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome.

Authors:  R M Gow
Journal:  Circulation       Date:  2001-01-30       Impact factor: 29.690

2.  Biophysical characterization of the new human ether-a-go-go-related gene channel opener NS3623 [N-(4-bromo-2-(1H-tetrazol-5-yl)-phenyl)-N'-(3'-trifluoromethylphenyl)urea].

Authors:  Rie Schultz Hansen; Thomas Goldin Diness; Torsten Christ; Erich Wettwer; Ursula Ravens; Søren-Peter Olesen; Morten Grunnet
Journal:  Mol Pharmacol       Date:  2006-07-06       Impact factor: 4.436

Review 3.  Targeted therapy for short QT syndrome.

Authors:  Preben Bjerregaard; Arshad Jahangir; Ihor Gussak
Journal:  Expert Opin Ther Targets       Date:  2006-06       Impact factor: 6.902

4.  Structural basis of action for a human ether-a-go-go-related gene 1 potassium channel activator.

Authors:  Matthew Perry; Frank B Sachse; Michael C Sanguinetti
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-10       Impact factor: 11.205

5.  Mechanisms of pharmacological rescue of trafficking-defective hERG mutant channels in human long QT syndrome.

Authors:  Qiuming Gong; Melanie A Jones; Zhengfeng Zhou
Journal:  J Biol Chem       Date:  2005-12-16       Impact factor: 5.157

6.  Mechanism of action of a novel human ether-a-go-go-related gene channel activator.

Authors:  Oscar Casis; Søren-Peter Olesen; Michael C Sanguinetti
Journal:  Mol Pharmacol       Date:  2005-11-11       Impact factor: 4.436

7.  Tryptophan scanning mutagenesis of the HERG K+ channel: the S4 domain is loosely packed and likely to be lipid exposed.

Authors:  Rajesh N Subbiah; Mari Kondo; Terence J Campbell; Jamie I Vandenberg
Journal:  J Physiol       Date:  2005-09-15       Impact factor: 5.182

8.  Mallotoxin is a novel human ether-a-go-go-related gene (hERG) potassium channel activator.

Authors:  Haoyu Zeng; Irina M Lozinskaya; Zuojun Lin; Robert N Willette; David P Brooks; Xiaoping Xu
Journal:  J Pharmacol Exp Ther       Date:  2006-08-23       Impact factor: 4.030

Review 9.  [HERG K+ channel, the target of anti-arrhythmias drugs].

Authors:  Feng-ying Guan; Shi-jie Yang
Journal:  Yao Xue Xue Bao       Date:  2007-07

10.  2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels.

Authors:  Earl Gordon; Irina M Lozinskaya; Zuojun Lin; Simon F Semus; Frank E Blaney; Robert N Willette; Xiaoping Xu
Journal:  Mol Pharmacol       Date:  2007-11-27       Impact factor: 4.436

View more
  12 in total

1.  Channelopathies and drug discovery in the postgenomic era.

Authors:  Dayue Darrel Duan; Tong-hui Ma
Journal:  Acta Pharmacol Sin       Date:  2011-06       Impact factor: 6.150

Review 2.  Translational toxicology and rescue strategies of the hERG channel dysfunction: biochemical and molecular mechanistic aspects.

Authors:  Kai-ping Zhang; Bao-feng Yang; Bao-xin Li
Journal:  Acta Pharmacol Sin       Date:  2014-11-24       Impact factor: 6.150

3.  Pharmacological and electrophysiological characterization of AZSMO-23, an activator of the hERG K(+) channel.

Authors:  R Mannikko; M H Bridgland-Taylor; H Pye; S Swallow; N Abi-Gerges; M J Morton; C E Pollard
Journal:  Br J Pharmacol       Date:  2015-04-10       Impact factor: 8.739

4.  Development of potent small-molecule inhibitors to drug the undruggable steroid receptor coactivator-3.

Authors:  Xianzhou Song; Jianwei Chen; Mingkun Zhao; Chengwei Zhang; Yang Yu; David M Lonard; Dar-Chone Chow; Timothy Palzkill; Jianming Xu; Bert W O'Malley; Jin Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-15       Impact factor: 11.205

5.  Kinetic model for NS1643 drug activation of WT and L529I variants of Kv11.1 (hERG1) potassium channel.

Authors:  Laura L Perissinotti; Jiqing Guo; Pablo M De Biase; Colleen E Clancy; Henry J Duff; Sergei Y Noskov
Journal:  Biophys J       Date:  2015-03-24       Impact factor: 4.033

6.  Exploration of 3-Aminoazetidines as Triple Reuptake Inhibitors by Bioisosteric Modification of 3-α-Oxyazetidine.

Authors:  Minsoo Han; Chiman Song; Nakcheol Jeong; Hoh-Gyu Hahn
Journal:  ACS Med Chem Lett       Date:  2014-07-10       Impact factor: 4.345

7.  The gating charge pathway of an epilepsy-associated potassium channel accommodates chemical ligands.

Authors:  Ping Li; Zhuxi Chen; Haiyan Xu; Haifeng Sun; Hao Li; Hong Liu; Huaiyu Yang; Zhaobing Gao; Hualiang Jiang; Min Li
Journal:  Cell Res       Date:  2013-06-25       Impact factor: 25.617

8.  ML365 inhibits TWIK2 channel to block ATP-induced NLRP3 inflammasome.

Authors:  Xiao-Yan Wu; Jin-Yan Lv; Shi-Qing Zhang; Xin Yi; Zi-Wei Xu; Yuan-Xing Zhi; Bo-Xin Zhao; Jian-Xin Pang; Ken Kin Lam Yung; Shu-Wen Liu; Ping-Zheng Zhou
Journal:  Acta Pharmacol Sin       Date:  2021-08-02       Impact factor: 6.150

Review 9.  Neuronal and Cardiovascular Potassium Channels as Therapeutic Drug Targets: Promise and Pitfalls.

Authors:  Edward S A Humphries; Caroline Dart
Journal:  J Biomol Screen       Date:  2015-08-24

10.  Identification of small-molecule ion channel modulators in C. elegans channelopathy models.

Authors:  Qiang Jiang; Kai Li; Wen-Jing Lu; Shuang Li; Xin Chen; Xi-Juan Liu; Jie Yuan; Qiurong Ding; Feng Lan; Shi-Qing Cai
Journal:  Nat Commun       Date:  2018-09-26       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.